References
1. Lee B.Y., Bartsch S.M., Mui Y., et al. A systems approach to obesity. Nutr Rev. 2017; 75 (suppl 1): 94–106. DOI: http://doi.org/10.1093/nutrit/nuw049
2. Kontsevaya A., Shalnova S., Deev A., Breda J., Jewell J., Rakovac I., et al. Overweight and obesity in the Russian population: prevalence in adults and association with socioeconomic parameters and cardiovascular risk factors. Obes Facts. 2019; 12 (1): 103–14. DOI: http://doi.org/10.1159/000493885
3. Bass R., Eneli I. Severe childhood obesity: an under-recognised and growing health problem. Postgrad Med J. 2015; 91 (1081): 639–45. DOI: http://doi.org/10.1136/postgradmedj-2014-133033
4. Pereira-Santos M., Costa P.R., Assis A.M., et al. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev. 2015; 16 (4): 341–9. DOI: http://doi.org/10.1111/obr.12239
5. Nikitina I.L., Todiyeva А.М., Karonova T.L. Metabolic risks in children with obesity and deficit of vitamin D. Prakticheskaya meditsina [Practical Medicine]. 2017; (5): 48–52. (in Russian)
6. Fu Z., Xu C., Shu Y., et al. Serum 25-hydroxyvitamin D is associated with obesity and metabolic parameters in US children. Public Health Nutr. 2019; 23: 1–9. DOI: http://doi.org/10.1017/S1368980019001137
7. Vranić L., Mikolašević I., Milić S. Vitamin D deficiency: consequence or cause of obesity? Review. Medicina (Kaunas). 2019; 55 (9). DOI: http://doi.org/10.3390/medicina55090541
8. Zakharova I., Klimov L., Kuryaninova V., Nikitina I., Malyavskaya S., Dolbnya S., et al. Vitamin D insufficiency in overweight and obese children and adolescents. Front Endocrinol. 2019; 10: 103. DOI: http://doi.org/10.3389/fendo.2019.00103
9. Hypponen E., Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007; 85 (3): 860–8. DOI: http://doi.org/10.1093/ajcn/85.3.860
10. Yao Y., Zhu L., He L., et al. A meta-analysis of the relationship between vitamin D deficiency and obesity. Int J Clin Exp Med. 2015; 8 (9): 14 977–84.
11. Carrelli A., Bucovsky M., Horst R., et al. Vitamin D storage in adipose tissue of obese and normal weight women. J Bone Miner Res. 2017; 32 (2): 237242. DOI: http://doi.org/10.1002/jbmr.2979
12. Wamberg L., Christiansen T., Paulsen S.K., et al. Expression of vitamin D-metabolizing enzymes in human adipose tissue-the effect of obesity and diet-induced weight loss. Int J Obes (Lond). 2012; 37: 651–7. DOI: http://doi.org/10.1038/ijo.2012.112
13. Roizen J.D., Long C., Casella A., et al. obesity decreases hepatic 25-hydroxylase activity causing low serum 25-hydroxyvitamin D. J Bone Miner Res. 2019; 34 (6): 1068–73. DOI: http://doi.org/10.1002/jbmr.3686
14. Szymczak-Pajor I., Śliwińska A. Analysis of association between vitamin D deficiency and insulin resistance. Nutrients. 2019; 11 (4): 794. DOI: http://doi.org/10.3390/nu11040794
15. Mousa A., Naderpoor N., Teede H., et al. Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and metaanalysis of randomized controlled trials. Nutr Rev. 2018; 76: 380–94. DOI: http://doi.org/10.1093/nutrit/nux077
16. Klöting N., Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014; 15 (4): 277–87. DOI: http://doi.org/10.1007/s11154-014-9301-0
17. Pascale A.V., Finelli R., Giannotti R., Visco V., Fabbricatore D., Matula I., et al. Vitamin D, parathyroid hormone and cardiovascular risk: the good, the bad and the ugly. J Cardiovasc Med (Hagerstown). 2018; 19 (2): 62–6. DOI: http://doi.org/10.2459/JCM.0000000000000614
18. Raposo L., Martins S., Ferreira D., et al. Vitamin D, parathyroid hormone and metabolic syndrome – the PORMETS study. BMC Endocr Disord. 2017; 17 (1): 71. DOI: http://doi.org/10.1186/s12902-017-0221-3
19. Kong J., Li C.Y. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab. 2006; 290: E916–924. DOI: http://doi.org/10.1152/ajpendo.00410.2005
20. Bandera M.B., Tinahones F.J., Macías-González M. Commonalities in the association between PPARG and vitamin D related with obesity and carcinogenesis. PPAR Res. 2016; 2016: 2308249. DOI: http://doi.org/10.1155/2016/2308249
21. Mathieu S.V., Fischer K., Dawson-Hughes B., et al. Association between 25-hydroxyvitamin D status and components of body composition and glucose metabolism in older men and women. Nutrients. 2018; 10 (12): 1826. DOI: http://doi.org/10.3390/nu10121826
22. Malyavskaya S.I., Lebedev A. V., Kostrova G. N. Components of the metabolic syndrome in children and adolescents with different levels of vitamin D: a cross-sectional study. Voprosy sovremennoy pediatrii [Problems of Modern Pediatrics]. 2017; 16 (3): 213–9. DOI: http://doi.org/10.15690/vsp.v16i3.1731 (in Russian)
23. Malyavskaya S.I., Lebedev A. The relevance of metabolic phenotypes of obesity in childhood and adolescence. Al’manakh klinicheskoy meditsiny [Almanac of Clinical Medicine]. 2015; (42): 38–45. DOI: http://doi.org/10.18786/2072-0505-2015-42-38-45 (in Russian)
24. Malyavskaya S.I., Lebedev A. V.The metabolic portrait of obese children. Rossiyskiy vestnik perinatologii i pediatrii [Russian Bulletin of Perinatology and Pediatrics]. 2015; (6): 73–81. (in Russian)
25. WHO Growth reference 5–19 years. BMI-for-age (5–19 years). URL: https://www.who.int/growthref/who2007_bmi_for_age/en/ (date of access October 01, 2020)
26. Federal clinical guidelines (protocols) on management of children with endocrine pathology. In: I.I. Dedov, V.A. Peterkova (eds). Moscow: Praktika, 2014: 442 p. (in Russian)
27. Vasyukova O.V., Vitebskaya A.V. Insulin resistance in obese children: debate on assessment. Problemy endokrinologii [Problems of Endocrinology]. 2009; 55 (3): 8–12. DOI: https://doi.org/10.14341/probl20095538-12 (in Russian)
28. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96 (7): 1911–30. DOI: http://doi.org/10.1210/jc.2011-0385
29. Malyavskaya S.I., Kostrova G.N., Lebedev А.V., Golysheva Е.V. Provision of different age-group populations of Arkhangelsk city with vitamin D. Ekologiya cheloveka [Human Ecology]. 2016; (12): 37–42. (in Russian)
30. Jang H., Lee Y., Park K. Obesity and vitamin D insufficiency among adolescent girls and young adult women from Korea. Nutrients. 2019; 11 (12): 3049. DOI: http://doi.org/10.3390/nu11123049
31. Walsh J.S., Bowles S., Evans A.L. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes. 2017; 24: 389–94. DOI: http://doi.org/10.1097/MED.0000000000000371
32. Gangloff A., Bergeron J., Lemieux I., Després J.-P. Changes in circulating vitamin D levels with loss of adipose tissue. Curr Opin Clin Nutr Metab Care. 2016; 19: 464–70. DOI: http://doi.org/10.1097/MCO.0000000000000315
33. Pigarova E.A., Rozhinskaya L.Y., Belaya J.E., Dzeranova L.K., Karonova T.L., Il’yin A.V., et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problemy endokrinologii [Problems of Endocrinology]. 2016; 62 (4): 60–84. DOI: https://doi.org/10.14341/probl201662460-84 (in Russian)
34. National program «Vitamin D deficiency in children and adolescents of the Russian Federation: modern approaches to treatment». In: Union of Pediatrcians of Russia, et al. Moscow: Pediatr, 2018: 96 p. (in Russian)
35. Wimalawansa S.J. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. J Steroid Biochem Mol Biol. 2018; 175: 177–89. DOI: http://doi.org/10.1016/j.jsbmb.2016.09.017
36. Manna P., Achari A.E., Jain S.K. 1,25(OH)2-vitamin D3 upregulates glucose uptake mediated by SIRT1/IRS1/GLUT4 signaling cascade in C2C12 myotubes. Mol Cell Biochem. 2018; 444: 103–8. DOI: http://doi.org/10.1007/s11010-017-3235-2
37. Rafiq S., Jeppesen P.B. Is hypovitaminosis D related to incidence of type 2 diabetes and high fasting glucose level in healthy subjects: a systematic review and meta-analysis of observational studies. Nutrients. 2018; 10 (1): 1–18. DOI: http://doi.org/10.3390/nu10010059
38. Greco E.A., Lenzi A., Migliaccio S. Role of hypovitaminosis D in the pathogenesis of obesity-induced insulin resistance. Nutrients. 2019; 11 (7): 1506. DOI: http://doi.org/10.3390/nu11071506
39. Alkharfy K.M., Al-Daghri N.M., Yakout S.M., et al. Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes. Metab Syndr Relat Disord. 2013; 11 (4): 283–8. DOI: http://doi.org/10.1089/met.2012.0068
40. Manna P., Jain S.K. Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-γ-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes. J Biol Chem. 2012; 287 (50): 42 324–32. DOI: http://doi.org/10.1074/jbc.M112.407833
41. Sergeev I.N. 1,25-Dihydroxyvitamin D3 and type 2 diabetes: Ca2+-dependent molecular mechanisms and the role of vitamin D status. Horm Mol Biol Clin Investig. 2016; 26 (1): 61–5. DOI: http://doi.org/10.1515/hmbci-2015-0069
42. Mousa A., Naderpoor N., Teede H., et al. Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2018; 76: 380–94. DOI: http://doi.org/10.1093/nutrit/nux077